AIMC Topic: Drug Discovery

Clear Filters Showing 1031 to 1040 of 1566 articles

Applications of deep learning for the analysis of medical data.

Archives of pharmacal research
Over the past decade, deep learning has demonstrated superior performances in solving many problems in various fields of medicine compared with other machine learning methods. To understand how deep learning has surpassed traditional machine learning...

Multiclass Classifier for P-Glycoprotein Substrates, Inhibitors, and Non-Active Compounds.

Molecules (Basel, Switzerland)
P-glycoprotein (P-gp) is a transmembrane protein that actively transports a wide variety of chemically diverse compounds out of the cell. It is highly associated with the ADMET (absorption, distribution, metabolism, excretion and toxicity) properties...

Deep Learning to Therapeutically Target Unreported Complexes.

Trends in pharmacological sciences
The disruption of large protein-protein (PP) interfaces remains a challenge in targeted therapy. Designing drugs that compete with binding partners is daunting, especially when the structure of the protein complex is unknown. To address the problem w...

Identification of the lipid-lowering component of triterpenes from Alismatis rhizoma based on the MRM-based characteristic chemical profiles and support vector machine model.

Analytical and bioanalytical chemistry
It has been demonstrated that triterpenes in Alismatis rhizoma (Zexie in Chinese, ZX) contributed to the lipid-lowering effect on high-fat diet-induced hyperlipidemia. Alisol B 23-acetate, one of the abundant triterpenes in ZX, was used as the marker...

Exploring the Potential of Spherical Harmonics and PCVM for Compounds Activity Prediction.

International journal of molecular sciences
Biologically active chemical compounds may provide remedies for several diseases. Meanwhile, Machine Learning techniques applied to Drug Discovery, which are cheaper and faster than wet-lab experiments, have the capability to more effectively identif...

Exploiting machine learning for end-to-end drug discovery and development.

Nature materials
A variety of machine learning methods such as naive Bayesian, support vector machines and more recently deep neural networks are demonstrating their utility for drug discovery and development. These leverage the generally bigger datasets created from...

Applications of machine learning in GPCR bioactive ligand discovery.

Current opinion in structural biology
GPCRs constitute the largest druggable family having targets for 475 Food and Drug Administration (FDA) approved drugs. As GPCRs are of great interest to pharmaceutical industry, enormous efforts are being expended to find relevant and potent GPCR li...

Computational advances in combating colloidal aggregation in drug discovery.

Nature chemistry
Small molecule effectors are essential for drug discovery. Specific molecular recognition, reversible binding and dose-dependency are usually key requirements to ensure utility of a novel chemical entity. However, artefactual frequent-hitter and assa...